Upper respiratory tract mucosal immunity for SARS-CoV-2 vaccines (2023)
Attributed to:
Optimising Innate Host Defence to Combat Antimicrobial Resistance
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Type: Journal Article/Review
Parent Publication: Trends Mol. Med.